Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2021 Q1- Text added to 2021 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Bad
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Bad
|
New words:
ACH, achondroplasia, analytical, analyzing, awaiting, Bai, batch, BioMarin, brain, Brown, cancelled, cartilage, category, Chair, Chinese, cisplatin, Comm, commenting, complement, concept, constitute, currency, Dollar, dwarfism, el, enrollee, epidemic, experimental, exposed, foreign, formulated, frustrated, GBM, Hedging, heighten, Insight, instrument, issuer, JCI, LB, liver, Mirzapoiazova, modified, multitude, NCI, neurosurgical, notoriously, online, original, origination, ovarian, paper, penetrate, PhD, preliminary, problematic, Professor, proof, prospectively, range, rationale, Ravi, refund, Regina, release, resistance, revealed, Salgia, SCLC, Shuhaibar, stimulating, stimulation, strong, temozolomide, undergoing, unrelated, urgent, urgently, vosoritide
Removed:
awarded, preclinical
Valuein 2021 Q1 filing- Value in 2021 Q2 filing
Original filings
Filing view